agilon health(AGL) - 2025 Q4 - Annual Report

Total Care Model and Partnerships - The agilon platform supports the transition to a Total Care Model, integrating technology, people, processes, and capital [22]. - The long-term partnership model with community-based physician groups typically lasts 20 years, providing a recurring revenue stream and visibility into financial trajectories [24]. - Under the Total Care Model, physicians are incentivized to improve care quality and efficiency, sharing in financial surpluses when premiums exceed medical costs [27]. - The company has entered into long-term professional service agreements with anchor physician groups, typically lasting 20 years, to manage medical costs and improve care quality [30]. - The company operates under a long-term partnership model with community-based physician groups to expand its geographic reach across the U.S. [46]. - The company emphasizes a Total Care Model that supports value-based care, aiming to attract new physicians to its network [46]. ACO Models and Payment Structures - The ACO REACH Model and MSSP participation involves nine approved ACOs, with selected risk-sharing options to manage total care costs for aligned beneficiaries [40]. - The ACO REACH Model will terminate at the end of 2026, transitioning to the Long-term Enhanced ACO Design (LEAD) Model, which will maintain core features but has many unknowns [42]. - ACO REACH will transition to a per Medicare beneficiary per month (PBPM) compensation model starting in 2025, moving away from fee-for-service (FFS) payments [43]. - In 2026, 75% of each ACO's governing body must be controlled by participating providers, and each ACO must include at least two beneficiary representatives on its board [44]. - The global capitation fees from health plan payor contracts are based on a defined percentage of monthly premium payments received from CMS for attributed members [34]. Compliance and Regulatory Environment - The company is committed to maintaining compliance with healthcare regulations, including those related to the corporate practice of medicine and fee-splitting prohibitions [71]. - The federal government has utilized the False Claims Act (FCA) to prosecute various alleged false claims against Medicare and other federal healthcare programs, with significant implications for compliance and financial penalties [78]. - Healthcare-related fraud remains the leading source of recoveries in FCA settlements and judgments, indicating a persistent focus on this area by regulatory authorities [77]. - Violations of the federal FCA can result in penalties of up to three times the actual damages, known as "treble damages," plus substantial penalties for each false claim submitted [81]. - The federal Anti-Kickback Statute (AKS) prohibits remuneration for referrals of services reimbursable under federal healthcare programs, with violations potentially leading to imprisonment of up to ten years and fines of up to $100,000 per offense [82]. - The Stark Law prohibits physicians from referring Medicare and Medicaid patients to entities with which they have a financial relationship, with civil penalties of up to $15,000 for each service arising from a prohibited referral [88]. - The Civil Monetary Penalties Law (CMPL) allows for civil monetary penalties against entities that present false claims or fail to report overpayments, with assessments of up to three times the total amount claimed for each violation [93]. - The Department of Justice (DOJ) has increased investigations into alleged improper coding under risk-adjustment methodologies, highlighting the importance of accurate documentation in claims submissions [79]. - States are expected to enact laws similar to the FCA, which may increase enforcement efforts and the potential for additional penalties [80]. - The ACA has influenced the interpretation of the AKS and Stark Law, broadening the scope of compliance requirements for healthcare providers [78]. - Compliance with the AKS and Stark Law is critical for healthcare organizations to avoid severe penalties and ensure eligibility for federal healthcare programs [84]. - The ACA has undergone significant changes since its enactment in 2010, including reduced funding, leading to uncertainty in long-term business planning [96]. - HIPAA mandates compliance audits with penalties for violations capped at $1.5 million for the same standard in a single calendar year [100]. - Violations of the TCPA can result in fines of up to $1,500 per instance, with no cap on statutory damages, potentially leading to millions in penalties [104]. - The Sherman Act imposes criminal penalties of up to $100 million for corporations found guilty of antitrust violations [105]. - The Clayton Act prohibits mergers that may substantially lessen competition, requiring advance notification for large mergers [108]. - The FCPA prohibits bribery of foreign officials and mandates internal controls to prevent violations, with severe penalties for non-compliance [111]. - Compliance programs are expected for organizations receiving government reimbursements, with best practices recommended for others [114]. - State laws may require licensing for operations related to utilization review and claims processing, varying significantly across states [112]. - The company maintains a compliance department to monitor adherence to federal and state laws applicable to healthcare entities [114]. Financial Overview - As of December 31, 2025, the company held cash, cash equivalents, restricted cash equivalents, and marketable securities totaling $285.1 million, down from $405.6 million in 2024 [402]. - The company is exposed to interest rate risk due to its floating rate debt under the Credit Facility, but a hypothetical 100 basis point change in interest rates would not have a material impact on interest expense [401]. - The company's investment policy focuses on liquidity and capital preservation, avoiding investments for trading or speculative purposes [402]. Technology and Innovation - The company has proprietary technology platforms, including CORE and HCC Manager, which aid in data aggregation and analysis [54].